Development of nitroalkene-based inhibitors to target STING-dependent inflammation

Información suplementaria en: https://doi.org/10.1016/j.redox.2024.103202

Saved in:
Bibliographic Details
Main Author: Chang, Fei (author)
Other Authors: Gunderstofte, Camila (author), Colussi, Nicole (author), Pitts, Mareena (author), Salvatore, S.R. (author), Thielke, Anne L. (author), Turell Novo, Lucía (author), Alvarez, Beatriz (author), Goldbach-Mansky, Raphaela (author), Villacorta, Luis (author), Holm, Christian K. (author), Schopfer, F.J. (author), Hansen, Anne Louise (author)
Format: article
Language:English
Published: 2024
Subjects:
Online Access:https://hdl.handle.net/20.500.12008/50451
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868890080538525696
author Chang, Fei
author2 Gunderstofte, Camila
Colussi, Nicole
Pitts, Mareena
Salvatore, S.R.
Thielke, Anne L.
Turell Novo, Lucía
Alvarez, Beatriz
Goldbach-Mansky, Raphaela
Villacorta, Luis
Holm, Christian K.
Schopfer, F.J.
Hansen, Anne Louise
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author_browse Alvarez, Beatriz
Chang, Fei
Colussi, Nicole
Goldbach-Mansky, Raphaela
Gunderstofte, Camila
Hansen, Anne Louise
Holm, Christian K.
Pitts, Mareena
Salvatore, S.R.
Schopfer, F.J.
Thielke, Anne L.
Turell Novo, Lucía
Villacorta, Luis
author_facet Chang, Fei
Gunderstofte, Camila
Colussi, Nicole
Pitts, Mareena
Salvatore, S.R.
Thielke, Anne L.
Turell Novo, Lucía
Alvarez, Beatriz
Goldbach-Mansky, Raphaela
Villacorta, Luis
Holm, Christian K.
Schopfer, F.J.
Hansen, Anne Louise
author_role author
collection COLIBRI
dc.contributor.none.fl_str_mv Chang Fei
Gunderstofte Camila
Colussi Nicole
Pitts Mareena
Salvatore S.R.
Thielke Anne L.
Turell Novo Lucía
Alvarez Beatriz, Universidad de la República (Uruguay). Facultad de Ciencias. Instituto de Química Biológica.
Goldbach-Mansky Raphaela
Villacorta Luis
Holm Christian K.
Schopfer F.J.
Hansen Anne Louise
dc.creator.none.fl_str_mv Chang, Fei
Gunderstofte, Camila
Colussi, Nicole
Pitts, Mareena
Salvatore, S.R.
Thielke, Anne L.
Turell Novo, Lucía
Alvarez, Beatriz
Goldbach-Mansky, Raphaela
Villacorta, Luis
Holm, Christian K.
Schopfer, F.J.
Hansen, Anne Louise
dc.date.none.fl_str_mv 2024
2025-07-02T16:41:56Z
2025-07-02T16:41:56Z
dc.format.none.fl_str_mv 14 h
application/pdf
dc.identifier.none.fl_str_mv Chang, F, Gunderstofte, C, Colussi, N [y otros autores]. "Development of nitroalkene-based inhibitors to target STING-dependent inflammation". Redox Biology. [en línea] 2024, 74: 103202. 14 h. DOI: 10.1016/j.redox.2024.103202
2213-2317
https://hdl.handle.net/20.500.12008/50451
10.1016/j.redox.2024.103202
dc.language.none.fl_str_mv en
eng
dc.publisher.none.fl_str_mv Elsevier
dc.relation.none.fl_str_mv Redox Biology, 2024, 74: 103202.
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
Licencia Creative Commons Atribución - No Comercial - Sin Derivadas (CC - By-NC-ND 4.0)
dc.source.none.fl_str_mv reponame:COLIBRI
instname:Universidad de la República
instacron:Universidad de la República
dc.subject.none.fl_str_mv Stimulator of Interferon Genes
Drug discovery Nitroalkene-based compounds
STING inhibitors
STING-associated vasculopathy with onset in infancy
Interferon
dc.title.none.fl_str_mv Development of nitroalkene-based inhibitors to target STING-dependent inflammation
dc.type.none.fl_str_mv Artículo
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
description Información suplementaria en: https://doi.org/10.1016/j.redox.2024.103202
eu_rights_str_mv openAccess
format article
id anni_651cecf2a34cd0de2121c2c71a4d30f4
identifier_str_mv Chang, F, Gunderstofte, C, Colussi, N [y otros autores]. "Development of nitroalkene-based inhibitors to target STING-dependent inflammation". Redox Biology. [en línea] 2024, 74: 103202. 14 h. DOI: 10.1016/j.redox.2024.103202
2213-2317
10.1016/j.redox.2024.103202
instacron_str Universidad de la República
institution Universidad de la República
instname_str Universidad de la República
language eng
language_invalid_str_mv en
network_acronym_str anni
network_name_str oai-lr-anni
oai_identifier_str oai:colibri.udelar.edu.uy:20.500.12008/50451
publishDate 2024
publishDateSort 2024
publisher.none.fl_str_mv Elsevier
reponame_str COLIBRI
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv Licencia Creative Commons Atribución - No Comercial - Sin Derivadas (CC - By-NC-ND 4.0)
spelling Development of nitroalkene-based inhibitors to target STING-dependent inflammationChang, FeiGunderstofte, CamilaColussi, NicolePitts, MareenaSalvatore, S.R.Thielke, Anne L.Turell Novo, LucíaAlvarez, BeatrizGoldbach-Mansky, RaphaelaVillacorta, LuisHolm, Christian K.Schopfer, F.J.Hansen, Anne LouiseStimulator of Interferon GenesDrug discovery Nitroalkene-based compoundsSTING inhibitorsSTING-associated vasculopathy with onset in infancyInterferonInformación suplementaria en: https://doi.org/10.1016/j.redox.2024.103202Stimulator of Interferon Genes (STING) is essential for the inflammatory response to cytosolic DNA. Despite that aberrant activation of STING is linked to an increasing number of inflammatory diseases, the development of inhibitors has been challenging, with no compounds in the pipeline beyond the preclinical stage. We previously identified endogenous nitrated fatty acids as novel reversible STING inhibitors. With the aim of improving the specificity and efficacy of these compounds, we developed and tested a library of nitroalkene-based compounds for in vitro and in vivo STING inhibition. The structure-activity relationship study revealed a robustly improved electrophilicity and reduced degrees of freedom of nitroalkenes by conjugation with an aromatic moiety. The lead compounds CP-36 and CP-45, featuring a β-nitrostyrene moiety, potently inhibited STING activity in vitro and relieved STING-dependent inflammation in vivo. This validates the potential for nitroalkene compounds as drug candidates for STING modulation to treat STING-driven inflammatory diseases, providing new robust leads for preclinical development.ElsevierChang FeiGunderstofte CamilaColussi NicolePitts MareenaSalvatore S.R.Thielke Anne L.Turell Novo LucíaAlvarez Beatriz, Universidad de la República (Uruguay). Facultad de Ciencias. Instituto de Química Biológica.Goldbach-Mansky RaphaelaVillacorta LuisHolm Christian K.Schopfer F.J.Hansen Anne Louise2025-07-02T16:41:56Z2025-07-02T16:41:56Z2024Artículoinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion14 happlication/pdfChang, F, Gunderstofte, C, Colussi, N [y otros autores]. "Development of nitroalkene-based inhibitors to target STING-dependent inflammation". Redox Biology. [en línea] 2024, 74: 103202. 14 h. DOI: 10.1016/j.redox.2024.1032022213-2317https://hdl.handle.net/20.500.12008/5045110.1016/j.redox.2024.103202reponame:COLIBRIinstname:Universidad de la Repúblicainstacron:Universidad de la RepúblicaenengRedox Biology, 2024, 74: 103202.Las obras depositadas en el Repositorio se rigen por la Ordenanza de los Derechos de la Propiedad Intelectual de la Universidad de la República.(Res. Nº 91 de C.D.C. de 8/III/1994 – D.O. 7/IV/1994) y por la Ordenanza del Repositorio Abierto de la Universidad de la República (Res. Nº 16 de C.D.C. de 07/10/2014)info:eu-repo/semantics/openAccessLicencia Creative Commons Atribución - No Comercial - Sin Derivadas (CC - By-NC-ND 4.0)oai:colibri.udelar.edu.uy:20.500.12008/504512026-04-14T10:10:52Z
spellingShingle Development of nitroalkene-based inhibitors to target STING-dependent inflammation
Chang, Fei
Stimulator of Interferon Genes
Drug discovery Nitroalkene-based compounds
STING inhibitors
STING-associated vasculopathy with onset in infancy
Interferon
status_str publishedVersion
title Development of nitroalkene-based inhibitors to target STING-dependent inflammation
title_full Development of nitroalkene-based inhibitors to target STING-dependent inflammation
title_fullStr Development of nitroalkene-based inhibitors to target STING-dependent inflammation
title_full_unstemmed Development of nitroalkene-based inhibitors to target STING-dependent inflammation
title_short Development of nitroalkene-based inhibitors to target STING-dependent inflammation
title_sort Development of nitroalkene-based inhibitors to target STING-dependent inflammation
topic Stimulator of Interferon Genes
Drug discovery Nitroalkene-based compounds
STING inhibitors
STING-associated vasculopathy with onset in infancy
Interferon
url https://hdl.handle.net/20.500.12008/50451